Rectal Carcinoma

Oncology·MeSH: Rectal Neoplasms

25 drugs in development·10 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(9)

Drug	Company
Adjuvant Systemic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
BET Bromodomain Inhibitor ZEN-3694	Merus N.V. (MRUS)
cetuximab	GH Research PLC (GHRS)
FOLFOX	KYNTRA BIO INC. (KYNB)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
Hormone Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
leucovorin calcium/levoleucovorin	GH Research PLC (GHRS)
panitumumab	GH Research PLC (GHRS)
Tucatinib	PFIZER INC (PFE)

Phase 2(8)

Drug	Company
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5	CG Oncology, Inc. (CGON)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
Immune checkpoint inhibitor	KYNTRA BIO INC. (KYNB)
Ivonescimab	IGM Biosciences, Inc. (IGMS)
Nogapendekin Alfa	CG Oncology, Inc. (CGON)
ot-101	Oncotelic Therapeutics, Inc. (OTLC)

Phase 1(4)

Drug	Company
Aminolevulinic Acid	ENANTA PHARMACEUTICALS INC (ENTA)
leucovorin	PFIZER INC (PFE)
Muzastotug	IGM Biosciences, Inc. (IGMS)
Photodynamic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)

Preclinical(2)

Drug	Company
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)

Phase 1/Phase 2(1)

Drug	Company
leucovorin	GH Research PLC (GHRS)

Phase 4(1)

Drug	Company
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)

BioSniper tracks 25 drugs in development for Rectal Carcinoma across 10 companies.

There are 2 clinical trials targeting Rectal Carcinoma tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.